当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:181.92亿  总市值:181.92亿
流通股本:88.31亿   总股本:88.31亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金5,238,258,922.963,410,337,467.351,376,788,467.836,015,806,488.35
收到的税费返还25,806,199.314,182,018.715,329,512.9330,744,472
收到其他与经营活动有关的现金66,223,464.4441,925,822.1318,932,272.0392,129,838.51
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,330,288,586.73,466,445,308.191,401,050,252.766,438,680,798.86
购买商品、接受劳务支付的现金4,386,716,484.232,828,622,315.761,398,041,311.624,948,497,612.67
支付给职工以及为职工支付的现金704,791,211.13514,802,120.75319,852,039.97731,028,603.9
支付的各项税费260,840,307.38159,094,692.4175,099,823.41530,762,564.78
支付其他与经营活动有关的现金115,163,399.4867,410,294.4941,430,416.33148,060,233.18
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,467,511,402.223,569,929,423.411,834,423,591.336,358,349,014.53
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-137,222,815.52-103,484,115.22-433,373,338.5780,331,784.33
二、投资活动产生的现金流量:
收回投资收到的现金22,581,922.29,279,236.674,609,030.97-
取得投资收益收到的现金843,852.71842,619.47-120,427,359
处置固定资产、无形资产和其他长期资产收回的现金净额29,69920,0002,00035,886
处置子公司及其他营业单位收到的现金净额---157,320,969
收到的其他与投资活动有关的现金700,000300,000300,0002,713,695.28
投资活动现金流入的平衡项目0000
投资活动现金流入小计24,155,473.9110,441,856.144,911,030.97280,497,909.28
购建固定资产、无形资产和其他长期资产支付的现金545,005,408.01333,323,483.58202,094,208.67828,735,437.05
投资支付的现金203,931,308.21176,872,444.341,441,600165,048,811.64
取得子公司及其他营业单位支付的现金---66,190,245.54
支付其他与投资活动有关的现金39,728,300.891,200,0001,077,0002,750,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计788,665,017.11511,395,927.88244,612,808.671,062,724,494.23
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-764,509,543.2-500,954,071.74-239,701,777.7-782,226,584.95
三、筹资活动产生的现金流量:
取得借款收到的现金2,710,072,723.292,335,268,976.081,531,191,082.471,805,814,830.52
收到其他与筹资活动有关的现金159,130,243.5159,130,243.5-52,908,873.47
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,869,202,966.792,494,399,219.581,531,191,082.471,858,723,703.99
偿还债务支付的现金1,243,925,323.58956,620,672.93517,686,289.51,658,704,497.43
分配股利、利润或偿付利息支付的现金61,649,487.1538,023,920.7616,702,824.27463,603,314.39
支付其他与筹资活动有关的现金1,195,922,516.17949,864,753.71577,437,915.78680,012,607.15
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,501,497,326.91,944,509,347.41,111,827,029.552,802,320,418.97
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额367,705,639.89549,889,872.18419,364,052.92-943,596,714.98
四、汇率变动对现金及现金等价物的影响-4,277,0814,612,832.96-73,739.745,465,273.51
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-538,303,799.83-49,935,481.82-253,784,803.09-1,640,026,242.09
加:期初现金及现金等价物余额2,904,831,842.082,904,831,842.082,904,831,842.084,544,858,084.17
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,366,528,042.252,854,896,360.262,651,047,038.992,904,831,842.08
补充资料:
净利润-188,048,359.55-1,278,699,260.63
资产减值准备-3,927,034.19-36,752,062.95
固定资产和投资性房地产折旧-466,090,074.23-932,671,167.25
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-466,090,074.23-932,671,167.25
无形资产摊销-24,901,450.44-55,560,008.54
长期待摊费用摊销-608,590.44-1,217,180.88
处置固定资产、无形资产和其他长期资产的损失-36,244.07--808,182.23
固定资产报废损失-114,297.82-114,154.36
财务费用-32,947,142.56-26,241,182.63
投资损失-300,197.85--75,219,142.94
递延所得税-10,350,208.16-80,780,488.59
其中:递延所得税资产减少--950,521.42-59,914,974.2
递延所得税负债增加-11,300,729.58-20,865,514.39
存货的减少--250,941,175.19--2,349,410,419.96
经营性应收项目的减少--1,351,744,882.42-690,169,077.47
经营性应付项目的增加-760,721,062.12--624,134,233.74
现金的期末余额-2,854,896,360.26-2,904,831,842.08
减:现金的期初余额-2,904,831,842.08-4,544,858,084.17
公告日期2024-10-312024-08-302024-04-202024-04-20
审计意见(境内)标准无保留意见
TOP↑